Bruker Corp (BRKR) has released an update to notify the public and investors about an entry into a material definitive agreement.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
On February 1, 2024, Bruker Corporation entered into an agreement with institutional accredited investors to issue Series A, B, and C Senior Notes with aggregate principal amounts of CHF 50 million, CHF 146 million, and CHF 135 million respectively, at varying interest rates and maturing from 2034 to 2039. The sale is exempt from registration under the Securities Act of 1933, with a closing date expected around April 15, 2024, subject to customary conditions. The notes are unsecured and may be guaranteed by the company’s subsidiaries, with provisions for prepayment and specific covenants regarding the company’s financial ratios and operations. Proceeds will be used for various corporate purposes.
For further insights into BRKR stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.